test

Ilko Menkov

@Vestal Point Capital, Lp

Latest period2024 - Q3ReportedManaged Assets$1.319BTotal holdings69
Assets growth rate-1.67%Assets growth rate (2-Q avg)4.62%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Vestal Point Capital, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 69 positions.

Assets under management

The assets under management (AUM) of Vestal Point Capital, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.319B in assets, with a quarterly growth rate of -1.67% and a 2-quarter average growth rate of 4.62%. The portfolio is managed by Ilko Menkov, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
SNYSanofi Sa
Recent Activity
New Position
0.66%
$8.645M
150,000 shares@ $57.63 avg price
BRKRBruker Corp
Recent Activity
New Position
0.66%
$8.633M
125,000 shares@ $69.06 avg price
APGEApogee Therapeutics Inc
Recent Activity
New Position
0.61%
$8.018M
136,500 shares@ $58.74 avg price
TARSTarsus Pharmaceuticals Inc
Recent Activity
New Position
0.58%
$7.565M
230,000 shares@ $32.89 avg price
BDXBecton Dickinson & Co
Recent Activity
New Position
0.55%
$7.233M
30,000 shares@ $241.1 avg price
MDGLMadrigal Pharmaceuticals Inc
Recent Activity
New Position
0.49%
$6.367M
30,000 shares@ $212.22 avg price
LEGNLegend Biotech Corp
Recent Activity
New Position
0.47%
$6.091M
125,000 shares@ $48.73 avg price
URGNUrogen Pharma Ltd
Recent Activity
New Position
0.39%
$5.08M
400,000 shares@ $12.7 avg price
GERNGeron Corp
Recent Activity
New Position
0.37%
$4.767M
1.05M shares@ $4.54 avg price
ZVRAZevra Therapeutics Inc
Recent Activity
New Position
0.28%
$3.644M
525,000 shares@ $6.94 avg price